Dr. Robert Daniel Toto, MD

Dr. Toto practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Toto's NPI, 1245209725, was assigned on March 16, 2006. Dr. Toto graduated from University of Illinois College of Medicine - Chicago in 1977. Dr. Toto's Texas license number on file is F5779.

Dr. Toto's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Toto's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Toto is also affiliated with Parkland Memorial Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Toto to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Toto practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Toto's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Toto is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Toto's licenses on file in 4 states: Texas, California, Tennessee and Michigan.

Dmand AI lists acute kidney failure, chronic kidney disease and kidney disease among the conditions Dr. Toto treats.

CMS data shows 85 Medicare services from Dr. Toto across 3 procedure codes in 2024, all of them office visits, for 106 Medicare patients. Medicare paid $10,295 for them. Every service was in an office.

CMS counts 106 Medicare patients who saw Dr. Toto in 2024. The largest group is 75 to 84, with 45 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Toto's median patient age at 68, with 50% women.

In 2024, Dr. Toto wrote 318 Medicare Part D claims for 85 patients. 73% of them were for generic drugs. CMS names the drug for 179 of them, across 9 drugs with 11 or more claims each, at $58,241 in total drug cost. In 2023, CMS named 60 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Toto for performance year 2024, reported as part of a group. Dr. Toto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Toto as offering telehealth.

Dmand AI links 252 papers to Dr. Toto, published from 2003 to 2025. 2021 was the busiest year, with 24. The most frequent topics are Diabetes Mellitus, Type 2, Kidney Failure, Chronic and Glomerular Filtration Rate. Dr. Toto has published most often in Am J Kidney Dis. Dr. Toto's most frequent co-authors are Glenn Matthew Chertow, MD, Orson W. Moe, MD and Jula K. Inrig, MD.

Dmand AI links Dr. Toto to 10 clinical trials, 2 of them phase 4 studies. 2 are still active or recruiting. Conditions studied include Renal Insufficiency, Chronic, Renal Insufficiency and Hypertension. Akebia Therapeutics sponsors the most, 4. Open Payments lists research payments to Dr. Toto that name 4 trials.

CMS Open Payments shows 149 general payments to Dr. Toto from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. AstraZeneca Pharmaceuticals LP paid the most, $67,350. It also lists 12 research payments totaling $23,810 from 2018 to 2024, naming 4 clinical trials.

Dmand AI lists 3 awards for Dr. Toto, most recently America's Top Doctors in 2014.

Dr. Toto graduated from University of Illinois College of Medicine - Chicago in 1977.

Dr. Toto is in network with 23 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.